Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rellidep in Major Depressive Disorder
NCT00446719Phase 3Completed
- Sponsor
- Mount Sinai Hospital
- Start
- Aug 2007
- Primary completion
- Dec 2008
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of Rellidep in major depressive disorder (MDD), sponsored by Mount Sinai Hospital. Started Aug 2007; status: completed.
02
Drugs
Rellidep
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00446719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00446719.